Sequencing HNC

Emergence of notch signaling

Curtis R. Pickering, Thomas J. Ow, Jeffrey N. Myers

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Head and neck cancer is driven by the accumulation of genomic abnormalities. Classically these were characterized by chromosomal alterations and TP53 mutations, but recent sequencing studies have improved our understanding of the full spectrum of mutations in this disease. While a few oncogenes are found to be altered (PIK3CA, HRAS, CCND1), the most frequent events inactivate tumor suppressor genes (TP53, CDKN2A). A surprising new finding was the identification of mutations in the gene NOTCH1. These mutations demonstrate that NOTCH1 is an important tumor suppressor gene in head and neck and other squamous tumors. This has shed new light on the Notch pathway in head and neck cancer progression, and clarified our need to learn more about this pathway in the progression and biology of head and neck cancer.

Original languageEnglish (US)
Title of host publicationMolecular Determinants of Head and Neck Cancer
PublisherSpringer New York
Pages303-323
Number of pages21
ISBN (Electronic)9781461488156
ISBN (Print)9781461488149
DOIs
StatePublished - Jan 1 2014

Fingerprint

Head and Neck Neoplasms
Mutation
Tumor Suppressor Genes
Oncogenes
Neck
Head
Genes
Neoplasms

Keywords

  • Genomics
  • Head and neck cancer
  • Notch
  • Sequencing
  • Squamous

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pickering, C. R., Ow, T. J., & Myers, J. N. (2014). Sequencing HNC: Emergence of notch signaling. In Molecular Determinants of Head and Neck Cancer (pp. 303-323). Springer New York. https://doi.org/10.1007/978-1-4614-8815-6_15

Sequencing HNC : Emergence of notch signaling. / Pickering, Curtis R.; Ow, Thomas J.; Myers, Jeffrey N.

Molecular Determinants of Head and Neck Cancer. Springer New York, 2014. p. 303-323.

Research output: Chapter in Book/Report/Conference proceedingChapter

Pickering, CR, Ow, TJ & Myers, JN 2014, Sequencing HNC: Emergence of notch signaling. in Molecular Determinants of Head and Neck Cancer. Springer New York, pp. 303-323. https://doi.org/10.1007/978-1-4614-8815-6_15
Pickering CR, Ow TJ, Myers JN. Sequencing HNC: Emergence of notch signaling. In Molecular Determinants of Head and Neck Cancer. Springer New York. 2014. p. 303-323 https://doi.org/10.1007/978-1-4614-8815-6_15
Pickering, Curtis R. ; Ow, Thomas J. ; Myers, Jeffrey N. / Sequencing HNC : Emergence of notch signaling. Molecular Determinants of Head and Neck Cancer. Springer New York, 2014. pp. 303-323
@inbook{e62896f1639542bcabd26740da9b5124,
title = "Sequencing HNC: Emergence of notch signaling",
abstract = "Head and neck cancer is driven by the accumulation of genomic abnormalities. Classically these were characterized by chromosomal alterations and TP53 mutations, but recent sequencing studies have improved our understanding of the full spectrum of mutations in this disease. While a few oncogenes are found to be altered (PIK3CA, HRAS, CCND1), the most frequent events inactivate tumor suppressor genes (TP53, CDKN2A). A surprising new finding was the identification of mutations in the gene NOTCH1. These mutations demonstrate that NOTCH1 is an important tumor suppressor gene in head and neck and other squamous tumors. This has shed new light on the Notch pathway in head and neck cancer progression, and clarified our need to learn more about this pathway in the progression and biology of head and neck cancer.",
keywords = "Genomics, Head and neck cancer, Notch, Sequencing, Squamous",
author = "Pickering, {Curtis R.} and Ow, {Thomas J.} and Myers, {Jeffrey N.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/978-1-4614-8815-6_15",
language = "English (US)",
isbn = "9781461488149",
pages = "303--323",
booktitle = "Molecular Determinants of Head and Neck Cancer",
publisher = "Springer New York",

}

TY - CHAP

T1 - Sequencing HNC

T2 - Emergence of notch signaling

AU - Pickering, Curtis R.

AU - Ow, Thomas J.

AU - Myers, Jeffrey N.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Head and neck cancer is driven by the accumulation of genomic abnormalities. Classically these were characterized by chromosomal alterations and TP53 mutations, but recent sequencing studies have improved our understanding of the full spectrum of mutations in this disease. While a few oncogenes are found to be altered (PIK3CA, HRAS, CCND1), the most frequent events inactivate tumor suppressor genes (TP53, CDKN2A). A surprising new finding was the identification of mutations in the gene NOTCH1. These mutations demonstrate that NOTCH1 is an important tumor suppressor gene in head and neck and other squamous tumors. This has shed new light on the Notch pathway in head and neck cancer progression, and clarified our need to learn more about this pathway in the progression and biology of head and neck cancer.

AB - Head and neck cancer is driven by the accumulation of genomic abnormalities. Classically these were characterized by chromosomal alterations and TP53 mutations, but recent sequencing studies have improved our understanding of the full spectrum of mutations in this disease. While a few oncogenes are found to be altered (PIK3CA, HRAS, CCND1), the most frequent events inactivate tumor suppressor genes (TP53, CDKN2A). A surprising new finding was the identification of mutations in the gene NOTCH1. These mutations demonstrate that NOTCH1 is an important tumor suppressor gene in head and neck and other squamous tumors. This has shed new light on the Notch pathway in head and neck cancer progression, and clarified our need to learn more about this pathway in the progression and biology of head and neck cancer.

KW - Genomics

KW - Head and neck cancer

KW - Notch

KW - Sequencing

KW - Squamous

UR - http://www.scopus.com/inward/record.url?scp=85028870242&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028870242&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-8815-6_15

DO - 10.1007/978-1-4614-8815-6_15

M3 - Chapter

SN - 9781461488149

SP - 303

EP - 323

BT - Molecular Determinants of Head and Neck Cancer

PB - Springer New York

ER -